Investing.com - Gilead (NASDAQ:GILD) reported first quarter earnings that beat analysts' expectations on Thursday and revenue that fell short of forecasts.
The firm reported earnings per share of $1.76 on revenue of $5.28B. Analysts polled by Investing.com expected EPS of $1.61 on revenue of $5.31B. That compared to EPS of $1.48 on revenue of $5.09B in the same period a year earlier. The company had reported EPS of $1.44 on revenue of $5.8B in the previous quarter.
Gilead shares gained 0.38% to trade at $65.55 in after-hours trade following the report.
For the year, Gilead shares are up 4.4%, under-performing the Nasdaq which is up 23.51% year to date.
Gilead follows other major Healthcare sector earnings this month
On Tuesday, April 16, 2019, J&J reported first quarter EPS of $2.1 on revenue of $20.02B, compared to forecasts of EPS of $2.04 on revenue of $19.61B.
Pfizer earnings beat analyst's expectations on Tuesday, with first quarter EPS of $0.85 on revenue of $13.12B. Investing.com analysts expected EPS of $0.75 on revenue of $13B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar